Literature DB >> 22795494

Comparison of diffusion-weighted MRI with 18F-fluorodeoxyglucose-positron emission tomography/CT and electroencephalography in sporadic Creutzfeldt-Jakob disease.

Xiao-wei Xing1, Jia-tang Zhang, Fei Zhu, Lin Ma, Da-yi Yin, Wei-quan Jia, Xu-sheng Huang, Chuan-qiang Pu, Sen-yang Lang, Sheng-yuan Yu.   

Abstract

18F-fluorodeoxyglucose-positron emission tomography/CT (18F-FDG PET/CT) scanning may be a useful tool for early diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD), as it may reveal lowered cellular glucose transport and metabolism in the cortex, cerebellum and basal ganglia. The aim of the present study was to compare the findings from PET/CT, MRI and electroencephalography (EEG) for patients with sCJD, to explore whether typical sites or reliable patterns of regional metabolic change could be found and to evaluate the results of diagnostic imaging in the light of clinical symptomatology. Five patients with biopsy-confirmed sCJD and nine with probable sCJD (aged 36-68 years) were evaluated using PET/CT, diffusion-weighted (DW)-MRI and EEG. In 13 of the 14 patients (92.86%), PET/CT imaging detected extra regions with abnormalities in addition to the hyperintense areas shown with DW-MRI. Two patients with no abnormal DW-MRI findings in the basal ganglia had bilateral extrapyramidal signs accompanied by basal ganglia hypometabolism on PET. Eight patients (57.14%) had decreased FDG uptake in the thalamic nuclei on PET scans; however, DW-MRI did not identify corresponding hyperintense changes in the thalamic nuclei. In 11 patients (78.57%), DW-MRI revealed more regions with abnormalities than EEG, and 10 patients (71.43%) had DW-MRI abnormalities in the thalamic nuclei and basal ganglia that EEG was unable to detect. There was a high level of correspondence among the PET/CT, DW-MRI and EEG results, with PET revealing more abnormal regions than the other imaging modalities. In the absence of neuropathological findings, FDG-PET could improve the accuracy of sCJD diagnosis when combined with DW-MRI and EEG, particularly for differentiating sCJD from paraneoplastic syndromes. Our results suggest that PET/CT is able to detect sCJD at an earlier stage and with greater sensitivity than DW-MRI.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795494     DOI: 10.1016/j.jocn.2011.11.035

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

Authors:  Elena Prieto; Inés Domínguez-Prado; Mario Riverol; Sara Ortega-Cubero; María Jesús Ribelles; María Rosario Luquin; Purificación de Castro; Javier Arbizu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-04       Impact factor: 9.236

2.  Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology.

Authors:  Jordi A Matías-Guiu; Carmen Guerrero-Márquez; María Nieves Cabrera-Martín; Ulises Gómez-Pinedo; María Romeral; Diego Mayo; Jesús Porta-Etessam; Teresa Moreno-Ramos; José Luis Carreras; Jorge Matías-Guiu
Journal:  Prion       Date:  2017-05-16       Impact factor: 3.931

3.  Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.

Authors:  Madhavi Tripathi; Manjari Tripathi; Nishikant Damle; Suman Kushwaha; Abhinav Jaimini; Maria M D'Souza; Rajnish Sharma; Sanjiv Saw; Anupam Mondal
Journal:  Neuroradiol J       Date:  2014-02-24

4.  Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis.

Authors:  Dimitri Renard; Rik Vandenberghe; Laurent Collombier; Pierre-Olivier Kotzki; Jean-Pierre Pouget; Vincent Boudousq
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

5.  Combined findings of FDG-PET and arterial spin labeling in sporadic Creutzfeldt-Jakob disease.

Authors:  Junliang Yuan; Shuangkun Wang; Wenli Hu
Journal:  Prion       Date:  2018-10-09       Impact factor: 3.931

6.  18FDG PET-CT in sporadic Creutzfeldt-Jakob disease, correlated with MRI and histology.

Authors:  Nicholas C D Morley; Monika Hofer; Philip Wilkinson; Kevin M Bradley
Journal:  World J Nucl Med       Date:  2021-10-12

7.  18F-FP-CIT PET/CT in a case of probable sporadic Creutzfeldt-Jakob disease with parkinsonism as initial symptom.

Authors:  Songhan Tang; Xiaofeng Dou; Ying Zhang
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.